MedKoo Cat#: 145100 | Name: KA-2507

Description:

WARNING: This product is for research use only, not for human or veterinary use.

KA-2507 is a potent and selective inhibitor of HDAC6 (biochemical IC50 = 2.5 nmol/L). KA2507 demonstrates antitumor efficacy and immune modulatory effects in preclinical models of melanoma and colorectal cancer. KA2507 shows selective HDAC6 target engagement, good tolerability with no dose-limiting toxicity observed, and prolonged disease stabilization in a subset of patients, supporting further clinical investigations, potentially in combination with other immuno-oncology drugs.

Chemical Structure

KA-2507
KA-2507
CAS#1636894-46-6

Theoretical Analysis

MedKoo Cat#: 145100

Name: KA-2507

CAS#: 1636894-46-6

Chemical Formula: C16H14N6O2

Exact Mass: 322.1178

Molecular Weight: 322.33

Elemental Analysis: C, 59.62; H, 4.38; N, 26.07; O, 9.93

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
KA-2507; KA2507; KA 2507;
IUPAC/Chemical Name
4-((di(pyrazin-2-yl)amino)methyl)-N-hydroxybenzamide
InChi Key
LXHMTDHBMRZSHJ-UHFFFAOYSA-N
InChi Code
1S/C16H14N6O2/c23-16(21-24)13-3-1-12(2-4-13)11-22(14-9-17-5-7-19-14)15-10-18-6-8-20-15/h1-10,24H,11H2,(H,21,23)
SMILES Code
ONC(=O)C1=CC=C(CN(C2=NC=CN=C2)C3=NC=CN=C3)C=C1
Appearance
To be determined
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 -4 C for short term (days to weeks) or -20 C for long term(months to years).
Solubility
To be determined
Shelf Life
>2 years if stored properly
Drug Formulation
To be determined
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 322.33 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Tsimberidou AM, Beer PA, Cartwright CA, Haymaker C, Vo HH, Kiany S, Cecil ARL, Dow J, Haque K, Silva FA, Coe L, Berryman H, Bone EA, Nogueras-Gonzalez GM, Vining D, McElwaine-Johnn H, Wistuba II. Preclinical Development and First-in- Human Study of KA2507, a Selective and Potent Inhibitor of Histone Deacetylase 6, for Patients with Refractory Solid Tumors. Clin Cancer Res. 2021 Jul 1;27(13):3584-3594. doi: 10.1158/1078-0432.CCR-21-0238. Epub 2021 May 4. PMID: 33947698.